Back
9/2/2008
Newsmaker of the Day: Rose Gerber
Breast cancer survivor, advocate completes activist training
By DEBORAH STRASZHEIM
NORWICH BULLETIN -
September 2, 2008
In
the news:
Rose Gerber, a charter member of the Uncas Health District’s
Breast Health Action Council, recently completed Project LEAD
Institute, a science and advocacy training program for breast
cancer activists organized by the National Breast Cancer
Coalition Fund of Washington, D.C.
Background: Gerber, 44,
grew up in New Mexico and moved to Connecticut 10 years ago. Her
husband, Robert, is director of clinical research at Pfizer.
They live in East Lyme.
Health issue: In 2003, she was diagnosed with
breast cancer. Her daughter was 6 at the time and her son was 8.
“It was so hard,” she said. “The fear of leaving my children
without a mother and leaving my husband without a wife, that was
the most devastating.” Gerber had six months of chemotherapy, 33
treatments of radiation and a 52-week drug treatment through a
clinic trial. She has been in remission for four years.
Other posts: She became involved in breast
cancer advocacy work three years after her diagnosis. She
reviews grants for the Susan G. Komen Foundation and serves as
co-founder and program manager of the Eastern Connecticut
Hematology and Oncology Cancer Foundation’s One to One Breast
Cancer Mentoring program, which provides cancer support to
patients. In April, Gerber visited Washington with Connecticut’s
delegation when Senate Majority Leader Harry Reid, D-Nev.,
presented the Breast Cancer and Environmental Research Act to
the Senate.
About the program: Project
LEAD is the National Breast Cancer Coalition’s science training
course to help breast cancer activists influence research and
public policy. Graduates review grant proposals, serve on
Institutional Review Boards, work with researchers on clinical
trials and help explain scientific findings. The advocacy course
was July 29 to Aug. 3 in Denver.
Quotable: “If I could have people understand
one thing, it’s that breast cancer has not been eradicated yet.
It’s a very complex disease and it’s not one disease. It’s
multiple diseases,” Gerber said. “As advocates, I think we have
an obligation, I have an obligation, to be informed and
educated.”
Back
|